News

Intermarket transactions (IMTs) are a core part of the EMVS but present their own unique challenges.

Zāļu valsts aģentūra un Veselības inspekcija aicina būt vērīgiem un neiegādāties zāles nelikumīgās interneta vietnēs un sociālajos tīklos

The Latvian Medicines Verification Organization (LZVO) is launching The Newsletter No. 6, where you can find the most important information about events in the world of medicines verification in the second quarter of 2023.

There have been team changes in the Latvian Medicines Verification Organization (LZVO). Since July 17, 2023, Sanda Čerdinceva has taken on the role of the new Quality Manager.

In the 2nd quarter of 2023, 27 million transactions have been performed in the Latvian Medicines Verification System (LZVS), of which 7 million packages were decommissioned and supplied to patients.

To ensure that the Latvian Medicines Verification Organisation’s (LZVO) newsletters meet the needs of end users in terms of content and format, LZVO conducted a survey of end users in May of this year. Among those respondents (242 end users) who assessed the relevance and value of the newsletters’ information, 76% or 185 respondents rated the relevance and value of information as very good or good.